News articles about Aetna (NYSE:AET) have been trending somewhat positive this week, Accern reports. Accern ranks the sentiment of news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Aetna earned a media sentiment score of 0.07 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 45.0665327341453 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

Here are some of the media stories that may have impacted Accern Sentiment’s rankings:

Several research analysts have commented on AET shares. Credit Suisse Group lifted their price target on Aetna from $200.00 to $208.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 31st. Jefferies Group reaffirmed a “hold” rating and issued a $205.00 price target on shares of Aetna in a research report on Wednesday, January 31st. Cowen reaffirmed a “buy” rating and issued a $212.00 price target on shares of Aetna in a research report on Tuesday, January 30th. Piper Jaffray reaffirmed a “buy” rating and issued a $212.00 price target on shares of Aetna in a research report on Tuesday, January 30th. Finally, Citigroup cut Aetna from a “buy” rating to a “neutral” rating and boosted their price objective for the company from $187.89 to $212.00 in a research report on Wednesday, January 31st. Nine research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $189.50.

Shares of AET traded down $1.10 on Thursday, reaching $176.43. 1,243,509 shares of the stock traded hands, compared to its average volume of 2,497,278. The stock has a market cap of $57,963.63, a PE ratio of 17.89, a P/E/G ratio of 1.43 and a beta of 0.67. The company has a current ratio of 0.65, a quick ratio of 0.65 and a debt-to-equity ratio of 0.52. Aetna has a 12 month low of $128.79 and a 12 month high of $194.40.

Aetna (NYSE:AET) last released its quarterly earnings data on Tuesday, January 30th. The company reported $1.25 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.18 by $0.07. Aetna had a return on equity of 21.50% and a net margin of 3.15%. The business had revenue of $14.74 billion for the quarter, compared to analysts’ expectations of $14.79 billion. During the same period in the previous year, the business posted $0.08 earnings per share. Aetna’s quarterly revenue was down 6.2% on a year-over-year basis. equities analysts forecast that Aetna will post 11.02 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Thursday, April 12th will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.13%. The ex-dividend date is Wednesday, April 11th. Aetna’s dividend payout ratio (DPR) is 20.28%.

TRADEMARK VIOLATION WARNING: “Somewhat Favorable Media Coverage Somewhat Unlikely to Impact Aetna (AET) Stock Price” was published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this piece on another website, it was illegally stolen and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece can be accessed at

About Aetna

Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.

Insider Buying and Selling by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with's FREE daily email newsletter.